US HR3379

Bill

US HR3379

PRICED Act Price Relief, Innovation, and Competition for Essential Drugs Act

Introduced
06/20/2019

In Committee
06/21/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years. This bill allows biosimilars to be marketed five years after the reference brand-name biological product is licensed. Currently, brand-name biological products are provided a 12-year marketing-exclusivity period. This shortened marketing-exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.

AI Summary

This bill, the Price Relief, Innovation, and Competition for Essential Drugs Act (PRICED Act), amends the Public Health Service Act to shorten the exclusivity period for brand-name biological products from 12 years to 5 years. This means that biosimilar products, which are similar but not identical to the original biological product, can be marketed and sold 5 years after the reference brand-name biological product is licensed by the Food and Drug Administration (FDA). The changes made by this bill only apply to biological products licensed by the FDA after the enactment of this legislation.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (23)

Jan Schakowsky (D)*, Judy Chu (D), David Cicilline (D), Angie Craig (D), Rosa DeLauro (D), Lloyd Doggett (D), Chuy García (D), Pramila Jayapal (D), Marcy Kaptur (D), Ro Khanna (D), Raja Krishnamoorthi (D), Barbara Lee (D), Andy Levin (D), Grace Meng (D), Joe Morelle (D), Eleanor Holmes Norton (D), Alexandria Ocasio-Cortez (D), Mark Pocan (D), Jamie Raskin (D), Bobby Rush (D), Rashida Tlaib (D), Peter Welch (D), Bruce Westerman (R),

Last Action

Referred to the Subcommittee on Health. (on 06/21/2019)

Official Document

https://www.congress.gov/bill/116th-congress/house-bill/3379/all-info

(2 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://www.congress.gov/bill/116th-congress/house-bill/3379/all-info
BillText	https://www.congress.gov/116/bills/hr3379/BILLS-116hr3379ih.pdf
Bill	https://www.congress.gov/116/bills/hr3379/BILLS-116hr3379ih.pdf.pdf

Bill	Bill Name	Last Action	Type
HR8527	Fair Care Act of 2020	Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, the Judiciary, Oversight and Reform, House Administration, Rules, the Budget, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.	Related
S4796	Fair Care Act of 2020	Read twice and referred to the Committee on Finance.	Related

Bill > HR3379

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (23)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary